Alzheimer’s Research UK’s team of TCS London Marathon runners raised over £1million towards life-changing research to find a ...

Donanemab – one of the first drugs to slow down early-stage Alzheimer’s disease – will not be available on the NHS in ...

Heart-pounding obstacles, rugged terrains, and towering walls - it's going to be tough! Conquer an exhilarating obstacle event and turn your mud-splattered miles into life-changing dementia research.

You’ll get emails about our work and how you can take action to help us find a cure.

You’ll get emails about our work and how you can take action to help us find a cure.

In our 2024 Christmas Raffle, £52,402 was raised from ticket sales – 12.11% being spent on prizes, 43.9% on the expenses of running the raffle and 43.98% going on to fund the work of Alzheimer’s ...

New blood tests could transform dementia diagnosis and care – and we know most people would take one. But what do NHS staff ...

Blood tests are a promising new tool that could transform how dementia is diagnosed in the UK. These tests could help tackle some of the biggest challenges in the current diagnosis pathway – making it ...

With expertise in research, fundraising, policy and more, our staff are dedicated to making breakthroughs possible. Hilary Evans-Newton is the Chief Executive of Alzheimer’s Research UK. Hilary joined ...